SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-19-000506
Filing Date
2019-05-06
Accepted
2019-05-06 16:05:19
Documents
2
Period of Report
2019-05-02

Document Format Files

Seq Description Document Type Size
1 form4-05062019_040506.html 4  
1 form4-05062019_040506.xml 4 8038
2 ex24-05062019_040507.htm EX-24 4894
  Complete submission text file 0001415889-19-000506.txt   14231
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Issuer) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address
AHMED NADIM (Reporting) CIK: 0001731193 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34912 | Film No.: 19799314